Published in Blood Weekly, July 27th, 2000
"CMV infection is a major cause of morbidity in heart transplant patients," Ainat Beniaminovitz and colleagues from Columbia University, New York, reported. "With adequate prophylaxis, the incidence and severity of clinical infection can be significantly reduced.
"Previous studies have underscored the importance of periodic CMVIg infusions in disease attenuation. We investigated if a similar reduction in CMV infection...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.